Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Fangxin Hong"'
Autor:
Rachel A. Pozzar, Niya Xiong, Fangxin Hong, Christopher P. Filson, Peter Chang, Barbara Halpenny, Donna L. Berry
Publikováno v:
BMC medical informatics and decision making. 22(1)
Background Although treatment decisions for localized prostate cancer (LPC) are preference-sensitive, the extent to which individuals with LPC receive preference-concordant treatment is unclear. In a sample of individuals with LPC, the purpose of thi
Autor:
Rachel Pozzar, Donna L. Berry, Barbara Halpenny, Niya Xiong, Christopher P. Filson, Fangxin Hong
Publikováno v:
Cancer
Background Decision support tools improve decisional conflict and elicit patient preferences related to prostate cancer treatment. It was hypothesized that men using the Personal Patient Profile-Prostate (P3P) would be more likely to pursue guideline
Autor:
Janette Lawrence, Traci M. Blonquist, Sapna Syngal, Fangxin Hong, Matthew B. Yurgelun, Meghan Underhill-Blazey
Publikováno v:
Familial Cancer
Individuals at high risk for pancreatic cancer are recommended surveillance and healthy lifestyle behaviours and patient experience with recommendations are understudied. To describe engagement and experience with surveillance, tobacco and alcohol us
Publikováno v:
JCO Precis Oncol
PURPOSE The objectives of the study were to characterize the tumor burden dynamics on serial computed tomography scans in patients with advanced non–small-cell lung cancer treated with first-line pembrolizumab and to identify imaging markers for pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45860052f738c1da7080f7763ff1f45f
https://europepmc.org/articles/PMC8232801/
https://europepmc.org/articles/PMC8232801/
Autor:
Fangxin Hong, Robert Knoerl, Jennifer A. Ligibel, Donna L. Berry, Elahe Salehi, Emanuele Mazzola, Kaitlen Reyes, Nadine Jackson McCleary
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
BackgroundChemotherapy-induced peripheral neuropathy (CIPN) negatively affects physical function and chemotherapy dosing, yet, clinicians infrequently document CIPN assessment and/or adhere to evidence-based CIPN management in practice. The primary a
Autor:
Elad Sharon, David S. Morgan, Neil Palmisiano, Catherine Diefenbach, Reem Karmali, Stephen M. Ansell, Jakub Svoboda, Brad S. Kahl, Stefan K. Barta, Michael J. Robertson, Kevin A. David, Richard F. Ambinder, Ranjana H. Advani, Jonathon B. Cohen, Fangxin Hong, Timothy S. Fenske, Howard Streicher
Publikováno v:
Lancet Haematol
Summary Background Recognising that the immune suppressive microenvironment promotes tumour growth in Hodgkin lymphoma, we hypothesised that activating immunity might augment the activity of targeted chemotherapy. We evaluated the safety and activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1337124261649e9dfc1e4bd74a0f4c96
https://europepmc.org/articles/PMC7737486/
https://europepmc.org/articles/PMC7737486/
Autor:
Andrew J. Plodkowski, Jia Luo, Biagio Ricciuti, Joao Victor Machado Alessi, Zihan Wei, Matthew D. Hellmann, Hira Rizvi, Mizuki Nishino, Mehmet Altan, Peter Sawan, Brett W. Carter, John V. Heymach, Mark M. Awad, Fangxin Hong, Elizabeth Jimenez-Aguilar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundPatients with non–small cell lung cancer (NSCLC) and a poor Eastern Cooperative Oncology Group Performance Status (ECOG PS) have been excluded from phase III immunotherapy clinical trials. We sought to evaluate clinical outcomes to first-
Autor:
Andrew M. Evens, Andrew Quon, Brad S. Kahl, Thomas M. Habermann, Randy D. Gascoyne, Terrence P. Cescon, Jane N. Winter, Puneet Singh Cheema, Stephen M. Ansell, Timothy E. O'Brien, Philip A. Dy, Thomas E. Witzig, Julie E. Chang, Ranjana H. Advani, Fangxin Hong, Erik A. Ranheim
Publikováno v:
Clin Cancer Res
Purpose: We sought to improve upon frontline bendamustine/rituximab (BR) induction therapy followed by rituximab maintenance in untreated high-risk follicular lymphoma (FL). Patients and Methods: Patients were randomized to BR induction followed by 2
Autor:
Traci M. Blonquist, Fangxin Hong, Randy A. Jones, Julia H. Hayes, Niya Xiong, Peter Chang, Barbara Halpenny, Christopher P. Filson, Quoc-Dien Trinh, Leslie Wilson, Viraj A. Master, Mitchell H. Sokoloff, Donna L. Berry, Tracey L. Krupski, Martin G. Sanda, Gary W. Chien, Seth Wolpin
Publikováno v:
Urol Oncol
INTRODUCTION: Men diagnosed with localized prostate cancer must navigate a highly preference-sensitive decision between treatment options with varying adverse outcome profiles. We evaluated whether use of a decision support tool previously shown to d
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Medical Informatics and Decision Making
BMC Medical Informatics and Decision Making
Background Decisional conflict is associated with decision quality and may affect decision outcomes. In the health sciences literature, the Decisional Conflict Scale is widely used to measure decisional conflict, yet limited research has described th